Artemis Therapeutics (ATMS) Short Interest Ratio & Short Volume

Short interest is the volume of Artemis Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 100 shares of ATMS short. Learn More on Artemis Therapeutics' current short interest.

Artemis Therapeutics saw a decline in short interest in the month of April. As of April 15th, there was short interest totaling 100 shares, a decline of 83.3% from the previous total of 600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the sector of "medical" compare to Artemis Therapeutics: PURE Bioscience, Inc. (0.00%), Predictive Oncology Inc. (0.65%), Silo Pharma, Inc. (2.43%), XWELL, Inc. (1.68%), Oragenics, Inc. (2.07%), Avinger, Inc. (3.64%), Azitra, Inc. (1.25%), Avenue Therapeutics, Inc. (0.64%), Exicure, Inc. (2.40%), Fresh Tracks Therapeutics, Inc. (0.17%),

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.69 billion), Occidental Petroleum Co. ($3.22 billion), Coinbase Global, Inc. ($2.54 billion), T. Rowe Price Group, Inc. ($2.33 billion), Paramount Global ($2.10 billion), Verisk Analytics, Inc. ($2.03 billion), Etsy, Inc. ($1.67 billion), Old Dominion Freight Line, Inc. ($1.62 billion), CarMax, Inc. ($1.60 billion), and Extra Space Storage Inc. ($1.60 billion). View all of the most shorted stocks.

Short selling ATMS is an investing strategy that aims to generate trading profit from Artemis Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Artemis Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ATMS, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ATMS, twice per month. The most recent reporting period available is April, 15 2023.